Skip to content

Preventing Impingement in Total Hip Arthroplasty

Preventing Impingement in Total Hip Arthroplasty: a randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN40548578
Enrollment
108
Registered
2013-03-20
Start date
2009-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip osteoarthritis Musculoskeletal Diseases Coxarthrosis [arthrosis of hip]

Interventions

Patients will be randomly assigned to a total hip replacement procedure using an implant with non-modular neck or using an implant with a modular neck.

Sponsors

University of Warwick (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged older than 18 years, either sex who are able to give informed consent 2. Patients undergoing primary total hip replacement with a cementless femoral stem. 3. Patients who are physically fit to undergo surgery

Exclusion criteria

Exclusion criteria: 1. Patients with concomitant medical problem that will preclude operation 2. Patients with abnormal hip anatomy 3. Patients with spinal deformity

Design outcomes

Primary

MeasureTime frame
The proportion of patients in each group who have calculated impingement (calculated in virtual model from the precise orientation of that patient`s hip replacement measured during surgery) inside the intended impingement-free range of movement. Measured at baseline, six week and twelve months.

Secondary

MeasureTime frame
1. Oxford Hip Score 2. UCLA 3. EuroQol EQ-5D 4. Disability rating index 5. Clinical leg length and Range of Movement 6. Analysis of lysis / ingrowth patterns in Gruen zones (using AP pelvis for hips and lateral radiographs Measured at baseline, six week and twelve months.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026